MedChemCommun, 2040-2503

Journal

  1. 2018
  2. 2017
  3. 2016
  4. 2015
  5. 2014
  6. Serratice, M., Bertrand, B., Janssen, E. F. J., Hemelt, E., Zucca, A., Cocco, F., Cinellu, M. A., & Casini, A. (2014). Gold(I) compounds with lansoprazole-type ligands: synthesis, characterization and anticancer properties in vitro. MedChemComm, 5(9), 1418-1422. https://doi.org/10.1039/c4md00241e
  7. 2011
  8. Gabbiani, C., Mastrobuoni, G., Sorrentino, F., Dani, B., Rigobello, M. P., Bindoli, A., Cinellu, M. A., Pieraccini, G., Messori, L., & Casini, A. (2011). Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays. MedChemComm, 2(1), 50-54. https://doi.org/10.1039/c0md00181c

ID: 13323354